AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 129 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $958,000 | +95.5% | 16,002 | -8.2% | 0.00% | +33.3% |
| Q3 2019 | $490,000 | -23.3% | 17,427 | +3.3% | 0.00% | -25.0% |
| Q2 2019 | $639,000 | -11.7% | 16,877 | -9.0% | 0.00% | 0.0% |
| Q1 2019 | $724,000 | +84.7% | 18,542 | +0.9% | 0.00% | +33.3% |
| Q4 2018 | $392,000 | -48.4% | 18,376 | -4.3% | 0.00% | -40.0% |
| Q3 2018 | $760,000 | +1.2% | 19,200 | -2.3% | 0.01% | 0.0% |
| Q2 2018 | $751,000 | +31.3% | 19,662 | +3.3% | 0.01% | +25.0% |
| Q1 2018 | $572,000 | -1.2% | 19,029 | +2.7% | 0.00% | 0.0% |
| Q4 2017 | $579,000 | +23.7% | 18,521 | +10.9% | 0.00% | 0.0% |
| Q3 2017 | $468,000 | +57.0% | 16,698 | +7.2% | 0.00% | +33.3% |
| Q2 2017 | $298,000 | +42.6% | 15,581 | +27.1% | 0.00% | +50.0% |
| Q1 2017 | $209,000 | -25.1% | 12,257 | -19.8% | 0.00% | -33.3% |
| Q4 2016 | $279,000 | – | 15,277 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 767,502 | $45,927,000 | 23.65% |
| Chicago Capital Management, LLC | 250,401 | $14,984,000 | 12.57% |
| Foresite Capital Management III, LLC | 233,067 | $13,947,000 | 7.82% |
| Partner Investment Management, L.P. | 17,795 | $1,065,000 | 7.65% |
| RAMIUS ADVISORS LLC | 220,784 | $13,212,000 | 5.68% |
| Beryl Capital Management LLC | 550,426 | $32,937,000 | 5.31% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 647,460 | $38,744,000 | 5.28% |
| FNY Investment Advisers, LLC | 278,861 | $16,687,000 | 5.17% |
| WHITE SQUARE CAPITAL LLP | 112,500 | $6,732,000 | 4.87% |
| Casdin Capital, LLC | 860,000 | $51,462,000 | 4.73% |